IDEAS home Printed from https://ideas.repec.org/
MyIDEAS: Log in (now much improved!)

Citations for "The economic control of infectious diseases"

by Gersovitz, Mark & Hammer, Jeffrey S.

For a complete description of this item, click here. For a RSS feed for citations of this item, click here.
as in new window

  1. José García-Montalvo & Marta Reynal-Querol, 2002. "Fighting Against Malaria: Prevent Wars While Waiting For The "Miraculous" Vaccine," Working Papers. Serie EC 2002-31, Instituto Valenciano de Investigaciones Económicas, S.A. (Ivie).
  2. Douglas Gollin & Christian Zimmermann, 2008. "Malaria: Disease Impacts and Long-Run Income Differences," Center for Development Economics 2008-01, Department of Economics, Williams College.
  3. Azomahou, Theophile & Soete, Luc & Diene, Bity & Diene, Mbaye, 2012. "Optimal health investment with separable and non-separable preferences," MERIT Working Papers 047, United Nations University - Maastricht Economic and Social Research Institute on Innovation and Technology (MERIT).
  4. David Aadland & David Finnoff & Kevin X.D. Huang, 2010. "Syphilis Cycles," Vanderbilt University Department of Economics Working Papers 1006, Vanderbilt University Department of Economics.
  5. Aditya Goenka & Lin Liu & Manh-Hung Nguyen, 2011. "Infectious Diseases and Economic Growth," LERNA Working Papers 11.04.338, LERNA, University of Toulouse.
  6. Brahmbhatt, Milan & Dutta, Arindam, 2008. "On SARS type economic effects during infectious disease outbreaks," Policy Research Working Paper Series 4466, The World Bank.
  7. Mesnard, Alice & Seabright, Paul, 2008. "Migration and The Equilibrium Prevalence of Infectious Diseases," CEPR Discussion Papers 6651, C.E.P.R. Discussion Papers.
  8. Fenichel, Eli P., 2013. "Economic considerations for social distancing and behavioral based policies during an epidemic," Journal of Health Economics, Elsevier, vol. 32(2), pages 440-451.
  9. Toxvaerd, Flavio, 2010. "Recurrent Infection and Externalities in Prevention," CEPR Discussion Papers 8112, C.E.P.R. Discussion Papers.
  10. Goyal, Sanjeev & Vigier, Adrien, 2015. "Interaction, protection and epidemics," Journal of Public Economics, Elsevier, vol. 125(C), pages 64-69.
  11. Horan, Richard D. & Fenichel, Eli P. & Finnoff, David & Wolf, Christopher A., 2015. "Managing dynamic epidemiological risks through trade," Journal of Economic Dynamics and Control, Elsevier, vol. 53(C), pages 192-207.
  12. Casper Worm Hansen & Peter Sandholt Jensen & Peter Egedesø Madsen, 2016. "Information and Disease Prevention: Tuberculosis Dispensaries," Discussion Papers 16-01, University of Copenhagen. Department of Economics.
  13. Chanel, Olivier & Luchini, Stéphane & Massoni, Sébastien & Vergnaud, Jean-Christophe, 2011. "Impact of information on intentions to vaccinate in a potential epidemic: Swine-origin Influenza A (H1N1)," Social Science & Medicine, Elsevier, vol. 72(2), pages 142-148, January.
  14. Herrmann, Markus, 2010. "Monopoly pricing of an antibiotic subject to bacterial resistance," Journal of Health Economics, Elsevier, vol. 29(1), pages 137-150, January.
  15. Chris Papageorgiou & Petia Stoytcheva, . "What Do We Know About the Impact of AIDS on Cross-Country Income So Far?," Departmental Working Papers 2005-01, Department of Economics, Louisiana State University.
  16. Mesnard, Alice & Seabright, Paul, 2008. "Escaping Epidemics Through Migration? Quarantine Measures Under Asymmetric Information About Infection Risk," CEPR Discussion Papers 6653, C.E.P.R. Discussion Papers.
  17. Barrett, Scott & Hoel, Michael, 2009. "Optimal Disease Eradication," HERO On line Working Paper Series 2003:23, Oslo University, Health Economics Research Programme.
  18. Telalagic, S., 2012. "Optimal Treatment of an SIS Disease with Two Strains," Cambridge Working Papers in Economics 1229, Faculty of Economics, University of Cambridge.
  19. GAUDET, Gérard & HERRMANN, Markus, 2007. "The Economic Dynamics of Antibiotic Efficacy under Open Access," Cahiers de recherche 2007-04, Universite de Montreal, Departement de sciences economiques.
  20. Jean-Claude Berthelemy & Jean Gaudart & Josselin Thuilliez, 2015. "Prevention or treatment? The case of malaria," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01157279, HAL.
  21. Marlène Guillon & Josselin Thuilliez, 2015. "HIV and Rational risky behaviors: a systematic review of published empirical literature (1990-2013)," Université Paris1 Panthéon-Sorbonne (Post-Print and Working Papers) halshs-01222571, HAL.
  22. Anderson, Soren & Laxminarayan, Ramanan & Salant, Stephen W., 2010. "Diversity or Focus? Spending to Combat Infectious Diseases When Budgets Are Tight," Discussion Papers dp-10-15, Resources For the Future.
  23. Olivier Chanel & Stephane Luchini & Sébastien Massoni & Jean-Christophe Vergnaud, 2010. "Impact of information on intentions to vaccinate in a potential epidemic: swine-origin Influenza A (H1N1)," Working Papers halshs-00543967, HAL.
  24. Aditya Goenka & Lin Liu, 2012. "Infectious diseases and endogenous fluctuations," Economic Theory, Springer;Society for the Advancement of Economic Theory (SAET), vol. 50(1), pages 125-149, May.
  25. Terrence August & Tunay I. Tunca, 2006. "Network Software Security and User Incentives," Management Science, INFORMS, vol. 52(11), pages 1703-1720, November.
  26. Na Hao & Gervan Fearon, 2009. "Government Funding Policy Towards Communicable Diseases," Atlantic Economic Journal, International Atlantic Economic Society, vol. 37(2), pages 121-134, June.
  27. Gersovitz, Mark & Hammer, Jeffrey S., 2005. "Tax/subsidy policies toward vector-borne infectious diseases," Journal of Public Economics, Elsevier, vol. 89(4), pages 647-674, April.
  28. Forslid, Rikard & Herzing, Mathias, 2008. "On the Optimal Production Capacity for Influenza Vaccine," CEPR Discussion Papers 6808, C.E.P.R. Discussion Papers.
  29. M. Ceddia, 2012. "Optimal Disease Eradication in Sympatric Metapopulations," Environmental & Resource Economics, Springer;European Association of Environmental and Resource Economists, vol. 52(4), pages 499-530, August.
  30. Stéphane Mechoulan, 2005. "Market Structure and Communicable Diseases," Working Papers tecipa-241, University of Toronto, Department of Economics.
  31. Rowthorn, Robert & Toxvaerd, Flavio, 2012. "The Optimal Control of Infectious Diseases via Prevention and Treatment," CEPR Discussion Papers 8925, C.E.P.R. Discussion Papers.
  32. Sanjeev Goyal & Adrien Vigier, 2014. "Interaction, Protection and Epidemics," Cambridge Working Papers in Economics 1458, Faculty of Economics, University of Cambridge.
  33. Park, Hojeong, 2016. "A real option analysis for stochastic disease control and vaccine stockpile policy: An application to H1N1 in Korea," Economic Modelling, Elsevier, vol. 53(C), pages 187-194.
  34. Momota, Akira & Tabata, Ken & Futagami, Koichi, 2005. "Infectious disease and preventive behavior in an overlapping generations model," Journal of Economic Dynamics and Control, Elsevier, vol. 29(10), pages 1673-1700, October.
  35. Thomas Colignatus, 2004. "Modifying behaviour on STI including HIV and oncogenic HPV: a draft protocol for a registry open to the registered subject, generating the concept of a 'STI passport'," HEW 0412001, EconWPA.
  36. Christopher Costello & Nicolas Querou & Agnes Tomini, 2016. "Private eradication of mobile public bads," Working Papers 05-16, LAMETA, Universtiy of Montpellier.
  37. Javier Birchenall, 2007. "Escaping high mortality," Journal of Economic Growth, Springer, vol. 12(4), pages 351-387, December.
  38. Marcello Basili & Filippo Belloc, 2012. "How to Measure the Economic Impact of Vector-Borne Diseases at a Country Level: An Assessment," Department of Economics University of Siena 648, Department of Economics, University of Siena.
This information is provided to you by IDEAS at the Research Division of the Federal Reserve Bank of St. Louis using RePEc data.